Nora Isberner

Universitätsklinikum Würzburg — Germany

Medicine · Health Sciences

12h-index508citations33works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(12), Long-Term Effects of COVID-19(8), COVID-19 and healthcare impacts(5), Cytomegalovirus and herpesvirus research(4), Chronic Lymphocytic Leukemia Research(4)

Publications31 total

Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients
Journal of Antimicrobial Chemotherapy·2025
Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?
Clinical Rheumatology·2025· 1 citedOpen Access
Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
Health Care Management Science·2023· 16 citedOpen Access
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
Infection·2023Open Access
Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib
Journal of Pharmaceutical and Biomedical Analysis·2023· 14 cited
Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany
BMC Infectious Diseases·2023· 2 citedOpen Access
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Pharmaceutics·2022· 12 citedOpen Access
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort
Scientific Reports·2022· 3 citedOpen Access
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma
Cancers·2022· 9 citedOpen Access
Hospitalized patients dying with SARS-CoV-2 infection—An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry
PLoS ONE·2022· 2 citedOpen Access
COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
Journal of Hepatology·2022Open Access
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)
Infection·2022· 5 citedOpen Access
COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
United European Gastroenterology Journal·2022· 21 citedOpen Access
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum – Application to therapeutic drug monitoring
Clinical Biochemistry·2022· 7 cited
Convalescent Plasma Treatment for SARS-CoV-2 Infected High-risk Patients - a Matched Pair Analysis to the LEOSS Cohort
Research Square (Research Square)·2022· 2 citedOpen Access
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio
Journal of Pharmaceutical and Biomedical Analysis·2022· 27 cited
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial
Cancer Chemotherapy and Pharmacology·2021· 16 citedOpen Access
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
European Heart Journal·2021· 55 citedOpen Access
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and Germany
Frontiers in Artificial Intelligence·2021· 4 citedOpen Access
Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study
Journal of Clinical Medicine·2021· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Stefan Borgmann(16), Frank Hanses(16), Melanie Stecher(15), Kai Wille(14), Jörg Janne Vehreschild(13), Martin Hower(13), Lukas Tometten(12), Sebastian Dolff(11), Lisa Pilgram(11), Hartwig Klinker(11), Julia Lanznaster(10), Björn‐Erik Ole Jensen(10), Fatemeh Aghai(10), Christoph D. Spinner(10), Maria J. G. T. Vehreschild(10), Lukas Eberwein(9), Siegbert Rieg(9), Norma Jung(9), Maria Madeleine Ruethrich(9), Maria Madeleine Rüthrich(8)